Human Liver Cancer Organoid Growth Medium Plus
Research
Online Inquiry

Human Liver Cancer Organoid Growth Medium Plus

Cat.No: RESK-0699 Datasheet

Quantities:
- +
Product Details Related Products
Product Name Human Liver Cancer Organoid Growth Medium Plus
Catalog No. RESK-0699
Description Human Liver Cancer Organoid Growth Medium Plus is a serum-free complete medium designed for the establishment and long-term culture of liver cancer organoids derived from human cells or tissues. In the presence of a basement membrane matrix, the medium's specific components and abundant cytokines promote the rapid growth of liver cancer cells and their efficient formation into liver cancer organoids. The organoid formation process is smooth and rapid while maintaining high liver cancer cell identity and viability, supporting downstream studies of physiological function, disease research, and precision medicine. This Plus version is an upgraded formulation of the standard Human Liver Cancer Organoid Growth Medium. The buffer system and nutrient composition have been optimized, improving the medium's resistance to external environmental stress and its overall stability.
Intended Use For the establishment and long-term culture of human liver cancer organoids from cell- or tissue-derived samples. Applications include tumor disease modeling, drug efficacy evaluation, toxicity assessment, and precision medicine research based on liver cancer organoids.
Principle / Technology Organoid culture technology. When cells or tissue fragments are embedded in a basement membrane matrix, the medium's specific components and abundant cytokines drive liver cancer cells to rapidly grow and self-organize into three-dimensional liver cancer organoids while retaining tumor heterogeneity.
Sample Type Cells, tissues
Performance Range / Specifications Broad applicability: suitable for tumor disease modeling, drug efficacy evaluation, and toxicity assessment.
Efficient and stable culture performance while retaining tumor heterogeneity.
Plus version with optimized buffer system and nutrient composition for improved resistance to environmental stress and enhanced stability.
Reaction Conditions / Protocol Embed isolated human liver cancer cells or tissue fragments in a basement membrane matrix, then overlay with this medium for organoid establishment and long-term culture.
Components / Formulation Serum-free complete medium comprising Part I and Part II components, containing specific proprietary components and abundant cytokines optimized for human liver cancer organoid growth; upgraded Plus formulation with an optimized buffer system and nutrient composition.
Storage Conditions Part I: store at 2 °C to 8 °C, protected from light. Part II: store at -25 °C to -15 °C.
Shelf Life 12 months (Part I at 2 °C to 8 °C, protected from light; Part II at -25 °C to -15 °C).
Package Specifications 100 mL, 500 mL
Product Form Liquid
Shipping Conditions Part I: shipped with ice packs. Part II: shipped on dry ice.
Expiration Date / Stability Stable for 12 months when stored as recommended (Part I at 2 °C to 8 °C protected from light; Part II at -25 °C to -15 °C).
Regulatory / Compliance For research use only.
Compatibility Used together with a basement membrane matrix for three-dimensional organoid culture.
Recommended Buffer System Optimized buffer system in the Plus formulation, providing improved resistance to external environmental stress and enhanced medium stability.
Application Notes / Precautions Applicable to liver cancer organoids derived from human cells or tissues.
Supports tumor disease modeling, drug efficacy evaluation, toxicity assessment, and precision medicine research.
Store Part I at 2 °C to 8 °C protected from light and Part II at -25 °C to -15 °C.

For research use only, not for clinical use.

0
0

There is no product in your cart.